通化金马:2025年半年度财务报告

              通化金马药业集团股份有限公司

                  2025 年半年度财务报告

一、审计报告
半年度报告是否经过审计
□是  否
公司半年度财务报告未经审计。
二、财务报表
财务附注中报表的单位为：元
1、合并资产负债表
编制单位：通化金马药业集团股份有限公司

                                            2025 年 06 月 30 日

                                                                                                单位：元

              项目                            期末余额                          期初余额

 流动资产：

  货币资金                                            343,686,786.24                    274,177,490.80

  结算备付金

  拆出资金

  交易性金融资产                                        1,068,300.42                      1,088,562.40

  衍生金融资产

  应收票据

  应收账款                                            513,987,637.44                    499,551,966.08

  应收款项融资                                        26,732,881.25                      26,715,894.78

  预付款项                                              9,531,344.58                      10,568,328.57

  应收保费

  应收分保账款

  应收分保合同准备金

  其他应收款                                          18,503,825.19                      15,330,106.14
……